The Drug Development Journey for New Cancer Treatments - Part 2
Offered By: Imperial College London via YouTube
Course Description
Overview
Explore the second part of a 17-minute webinar presented by Professor Nick Turner, a renowned expert in breast cancer research and treatment. Delve into clinical studies on AKT inhibitors as part of the drug development journey for new cancer treatments. Gain insights from Turner's role as Team Leader at the Breast Cancer Now Toby Robins Research Centre and his experience as a Consultant Medical Oncologist at the Royal Marsden Hospital. Learn about cutting-edge research in cancer drug development and its potential impact on patient care. For a comprehensive understanding, view the first part of this presentation available through the provided link. Discover more about this research and related topics by visiting the official website of the Academic Health Science Centre.
Syllabus
The drug development journey for new cancer treatments – Prof. Nick Turner (Part 2 of 2)
Taught by
Imperial College London
Related Courses
Cancer in the 21st Century: The Genomic RevolutionUniversity of Glasgow via FutureLearn Inside Cancer: How Genes Influence Cancer Development
University of Bath via FutureLearn Cancer Immunotherapy: a Step Change in Cancer Treatment
University of Birmingham via FutureLearn Demystifying Targeted Cancer Treatments
Cancer Research UK via FutureLearn Discovering Science: Medicinal Chemistry
University of Leeds via FutureLearn